Meng Wan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Meng Wan has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Hewei Wu
Qilu Hospital of Shandong University 1 Department of Gastroenterology Jinan, China
13 shared publications - Iqtida Ahmed Mirza
Qilu Hospital of Shandong University 1 Department of Gastroenterology Jinan, China
13 shared publications - Jing Liu
Qilu Hospital of Shandong University 2 Department of Gastroenterology, (Qingdao), Qingdao, China
13 shared publications - Peizhu Wang
Qilu Hospital of Shandong University 1 Department of Gastroenterology Jinan, China
13 shared publications - Ruchen Zhou
Qilu Hospital of Shandong University 1 Department of Gastroenterology Jinan, China
13 shared publications - Shuchang Xu
Department of Gastroenterology, Tongji Institute of Digestive Diseases, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China
13 shared publications
Latest Publications
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S9 from Quantitative Fecal Immunochemical Test for Advanced Colorectal Neoplasia Risk Stratification
Supplementary Figure S9. Nomogram for predicting the risk of advanced colorectal neoplasia in asymptomatic patients. The nomogram integrates the same seven predictors as the main model, developed specifically for the asymptomatic screening population (n = 2,704). ACRN, advanced colorectal neoplasia; BMI, body mass index.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S9 from Quantitative Fecal Immunochemical Test for Advanced Colorectal Neoplasia Risk Stratification
Supplementary Figure S9. Nomogram for predicting the risk of advanced colorectal neoplasia in asymptomatic patients. The nomogram integrates the same seven predictors as the main model, developed specifically for the asymptomatic screening population (n = 2,704). ACRN, advanced colorectal neoplasia; BMI, body mass index.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Data from Quantitative Fecal Immunochemical Test for Advanced Colorectal Neoplasia Risk Stratification
Background:This study aimed to develop and externally validate a risk stratification model for advanced colorectal neoplasia (ACRN) based on the quantitative fecal immunochemical test (FIT) and easily available clinical data.Methods:Data were derived from a multicenter study, comprising 3,209 individuals in the development set and 1,678 in the validation set. Significant risk factors for ACRN were identified using multivariable logistic regression. The area under the receiver operating characteristic curve (AUROC) and the Hosmer–Lemeshow goodness-of-fit test were used to evaluate model performance. After point assignments based on the regression coefficients, patients in the validation set were categorized into low-, intermediate-, high-, and very high–risk tiers.Results:Age, sex, body mass index, habitual residence, alcohol intake, smoking, and fecal hemoglobin concentration were identified as significant risk factors for ACRN. The model demonstrated strong predictive performance (AUROC = 0.870) and good calibration (P = 0.929). The corresponding prevalence of ACRN in the low-, intermediate-, high-, and very high–risk tiers was 1.66%, 4.50%, 28.45%, and 60.64%, respectively. Subjects in the intermediate-, high-, and very high–risk tiers had 2.71-, 17.13-, and 36.51-fold higher risk of ACRN, respectively, compared with those in the low-risk tier.Conclusions:This model can effectively stratify the risk of ACRN. Individuals in the high-risk and very high–risk groups should undergo colonoscopy promptly. Furthermore, it may help compensate for the low detection rate of FIT for advanced adenoma.Impact:This model provides clinicians with a complementary approach to colorectal cancer screening strategy and may help optimize the efficiency of screening resource allocation.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessData from Quantitative Fecal Immunochemical Test for Advanced Colorectal Neoplasia Risk Stratification
Background:This study aimed to develop and externally validate a risk stratification model for advanced colorectal neoplasia (ACRN) based on the quantitative fecal immunochemical test (FIT) and easily available clinical data.Methods:Data were derived from a multicenter study, comprising 3,209 individuals in the development set and 1,678 in the validation set. Significant risk factors for ACRN were identified using multivariable logistic regression. The area under the receiver operating characteristic curve (AUROC) and the Hosmer–Lemeshow goodness-of-fit test were used to evaluate model performance. After point assignments based on the regression coefficients, patients in the validation set were categorized into low-, intermediate-, high-, and very high–risk tiers.Results:Age, sex, body mass index, habitual residence, alcohol intake, smoking, and fecal hemoglobin concentration were identified as significant risk factors for ACRN. The model demonstrated strong predictive performance (AUROC = 0.870) and good calibration (P = 0.929). The corresponding prevalence of ACRN in the low-, intermediate-, high-, and very high–risk tiers was 1.66%, 4.50%, 28.45%, and 60.64%, respectively. Subjects in the intermediate-, high-, and very high–risk tiers had 2.71-, 17.13-, and 36.51-fold higher risk of ACRN, respectively, compared with those in the low-risk tier.Conclusions:This model can effectively stratify the risk of ACRN. Individuals in the high-risk and very high–risk groups should undergo colonoscopy promptly. Furthermore, it may help compensate for the low detection rate of FIT for advanced adenoma.Impact:This model provides clinicians with a complementary approach to colorectal cancer screening strategy and may help optimize the efficiency of screening resource allocation.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S2 from Quantitative Fecal Immunochemical Test for Advanced Colorectal Neoplasia Risk Stratification
Supplementary Figure S2. Restricted cubic spline analysis of fecal immunochemical test (FIT) values by different methods. This diagram showed restricted cubic spline analysis for different methods: (a) logarithmic transformation [log(1+FIT)], (b) rank trans formation, (c) winsorization transformation and (d) raw FIT values.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from Quantitative Fecal Immunochemical Test for Advanced Colorectal Neoplasia Risk Stratification
Supplementary Figure S2. Restricted cubic spline analysis of fecal immunochemical test (FIT) values by different methods. This diagram showed restricted cubic spline analysis for different methods: (a) logarithmic transformation [log(1+FIT)], (b) rank trans formation, (c) winsorization transformation and (d) raw FIT values.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S1 from Quantitative Fecal Immunochemical Test for Advanced Colorectal Neoplasia Risk Stratification
Supplementary Figure S1. Distribution analysis of fecal immunochemical test (FIT) values by different methods. This diagram systematically evaluated four alternative approaches for handling the skewed distribution of raw FIT values (a): winsorization transformation (b), logarithmic transformation [log(1+FIT)] (c), rank transformation (d) and categorized transformation (e).
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from Quantitative Fecal Immunochemical Test for Advanced Colorectal Neoplasia Risk Stratification
Supplementary Figure S1. Distribution analysis of fecal immunochemical test (FIT) values by different methods. This diagram systematically evaluated four alternative approaches for handling the skewed distribution of raw FIT values (a): winsorization transformation (b), logarithmic transformation [log(1+FIT)] (c), rank transformation (d) and categorized transformation (e).
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S8 from Quantitative Fecal Immunochemical Test for Advanced Colorectal Neoplasia Risk Stratification
Supplementary Figure S8. The receiver operating characteristic curves and calibration curves of the model/qFIT only for advanced colorectal neoplasia in symptomatic/asymptomatic patients. (A) Receiver operating characteristic curves and (B) calibration curves of the model/qFIT only for advanced colorectal neoplasia in asymptomatic patients; (C) receiver operating characteristic curves and (D) calibration curves of the model/qFIT only for advanced colorectal neoplasia in symptomatic patients.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S8 from Quantitative Fecal Immunochemical Test for Advanced Colorectal Neoplasia Risk Stratification
Supplementary Figure S8. The receiver operating characteristic curves and calibration curves of the model/qFIT only for advanced colorectal neoplasia in symptomatic/asymptomatic patients. (A) Receiver operating characteristic curves and (B) calibration curves of the model/qFIT only for advanced colorectal neoplasia in asymptomatic patients; (C) receiver operating characteristic curves and (D) calibration curves of the model/qFIT only for advanced colorectal neoplasia in symptomatic patients.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S7 from Quantitative Fecal Immunochemical Test for Advanced Colorectal Neoplasia Risk Stratification
Supplementary Figure S7. Proportion of ACRN, AA and CRC according to the nomogram. Bar chart showing the prevalence of advanced colorectal neoplasia, advanced adenoma, and colorectal cancer across low-, intermediate-, high-, and very-high-risk groups in the validation set. ACRN, advanced colorectal neoplasia; AA, advanced adenoma; CRC, colorectal cancer.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S7 from Quantitative Fecal Immunochemical Test for Advanced Colorectal Neoplasia Risk Stratification
Supplementary Figure S7. Proportion of ACRN, AA and CRC according to the nomogram. Bar chart showing the prevalence of advanced colorectal neoplasia, advanced adenoma, and colorectal cancer across low-, intermediate-, high-, and very-high-risk groups in the validation set. ACRN, advanced colorectal neoplasia; AA, advanced adenoma; CRC, colorectal cancer.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S6 from Quantitative Fecal Immunochemical Test for Advanced Colorectal Neoplasia Risk Stratification
Supplementary Figure S6. Comparison of our model with the “APCS + Binary FIT” model. ROC curves comparing the full risk model (AUROC = 0.87) and the APCS score combined with binary FIT result (AUROC = 0.80) in the validation set (P < 0.001, DeLong’s test).
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S6 from Quantitative Fecal Immunochemical Test for Advanced Colorectal Neoplasia Risk Stratification
Supplementary Figure S6. Comparison of our model with the “APCS + Binary FIT” model. ROC curves comparing the full risk model (AUROC = 0.87) and the APCS score combined with binary FIT result (AUROC = 0.80) in the validation set (P < 0.001, DeLong’s test).
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S5 from Quantitative Fecal Immunochemical Test for Advanced Colorectal Neoplasia Risk Stratification
Supplementary Figure S5. Calibration curve for the prediction model in the external validation set. Calibration plot showing agreement between predicted and observed advanced colorectal neoplasm risk in the validation set (n = 1,678).
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S5 from Quantitative Fecal Immunochemical Test for Advanced Colorectal Neoplasia Risk Stratification
Supplementary Figure S5. Calibration curve for the prediction model in the external validation set. Calibration plot showing agreement between predicted and observed advanced colorectal neoplasm risk in the validation set (n = 1,678).
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S4 from Quantitative Fecal Immunochemical Test for Advanced Colorectal Neoplasia Risk Stratification
Supplementary Figure S4. Calibration curve for the prediction model in the internal validation. Calibration plot showing agreement between predicted and observed advanced colorectal neoplasm risk after 100 bootstrap resampling iterations in the development set.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from Quantitative Fecal Immunochemical Test for Advanced Colorectal Neoplasia Risk Stratification
Supplementary Figure S4. Calibration curve for the prediction model in the internal validation. Calibration plot showing agreement between predicted and observed advanced colorectal neoplasm risk after 100 bootstrap resampling iterations in the development set.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S3 from Quantitative Fecal Immunochemical Test for Advanced Colorectal Neoplasia Risk Stratification
Supplementary Figure S3. Receiver operating characteristic curves for restricted cubic spline analysis of different FIT transformation methods. Comparison of ROC curves for models using raw FIT, log-transformed FIT, winsorized FIT, and categorized FIT in predicting ACRN. AUC values are shown for each method. AUC, area under curve.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from Quantitative Fecal Immunochemical Test for Advanced Colorectal Neoplasia Risk Stratification
Supplementary Figure S3. Receiver operating characteristic curves for restricted cubic spline analysis of different FIT transformation methods. Comparison of ROC curves for models using raw FIT, log-transformed FIT, winsorized FIT, and categorized FIT in predicting ACRN. AUC values are shown for each method. AUC, area under curve.